Alzheimer's disease (AD), which is pathologically characterized by brain tissue atrophy, amyloid plaque formation [β-amyloid (Aβ)], neurofibrillary tangles (mainly tau protein) formation, neuronal synapse loss, etc., was first described by the German pathologist Alzheimer in 1906. This evidence concerns the gene MAPT and Alzheimer disease.